Scientific illustration of researchers discovering SLC35F2 transporter enabling queuine and queuosine uptake in human cells.
Scientific illustration of researchers discovering SLC35F2 transporter enabling queuine and queuosine uptake in human cells.
Hoton da AI ya samar

Researchers identify SLC35F2 as a transporter that brings the micronutrients queuine and queuosine into human cells

Hoton da AI ya samar
An Binciki Gaskiya

An international research team has identified the human gene SLC35F2 as a transporter that enables cellular uptake of the micronutrients queuine and queuosine—compounds acquired from diet and gut bacteria. The work, published in the Proceedings of the National Academy of Sciences, addresses a long-standing question about how these tRNA-related nutrients enter human cells.

An international team led in part by scientists at the University of Florida and Trinity College Dublin has identified SLC35F2 as a key gene involved in bringing the micronutrients queuine and queuosine into human cells.

The researchers reported that queuosine is a vitamin-like compound that humans cannot synthesize and instead obtain from certain foods and from bacteria in the gut. The nutrient is tied to transfer RNA (tRNA) biology, and the team said it influences how cells translate genetic information into proteins.

The findings were published in the Proceedings of the National Academy of Sciences (PNAS) in a paper titled “The oncogene SLC35F2 is a high-specificity transporter for the micronutrients queuine and queuosine.” The ScienceDaily summary, based on materials from the University of Florida, described the result as resolving a question researchers have pursued for decades: how queuosine enters cells.

Valérie de Crécy-Lagard, a microbiology and cell science professor at the University of Florida and one of the study’s principal investigators, said researchers had long suspected a transporter existed. She also characterized queuosine as “like a nutrient that fine-tunes how your body reads your genes,” in reference to its role in processes affecting gene-to-protein translation.

The team said SLC35F2 had previously been studied in other contexts—such as how certain viruses and some cancer drugs enter cells—while its role in normal nutrient uptake was not clearly established. Vincent Kelly, a professor at Trinity College Dublin and a senior author on the paper, said scientists have long linked queuosine to processes including brain health, metabolic regulation, cancer and responses to stress, but that the mechanism for how it is salvaged from the gut and distributed into cells had not been clear.

According to the research organizations’ materials, the project involved researchers across multiple institutions, including the University of Florida and Trinity College Dublin, and received support from funding bodies including the U.S. National Institutes of Health, Research Ireland, and Health and Social Care in Northern Ireland. The researchers said the identification of the transporter could support further work on how diet and the microbiome affect human biology and may help guide future therapeutic research.

Abin da mutane ke faɗa

Initial reactions on X to the identification of SLC35F2 as the transporter for queuine and queuosine are positive and limited. Users describe it as solving a 30-year mystery with implications for brain health, memory, stress response, and cancer defense. Posts emphasize the role of diet and gut bacteria in nutrient uptake.

Labaran da ke da alaƙa

Researchers in a lab studying a 3D mitochondrion model with leucine molecules, illustrating how the amino acid boosts cellular energy for metabolic disease and cancer insights.
Hoton da AI ya samar

Researchers map how leucine helps mitochondria ramp up energy

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

A University of Cologne team reports in Nature Cell Biology that the essential amino acid leucine enhances cellular energy production by preserving key outer‑mitochondrial‑membrane proteins through the quality‑control factor SEL1L, linking diet to organelle function and hinting at implications for metabolic disease and cancer.

Researchers led by Helmholtz Munich report that some gut-dwelling bacteria — including strains not typically considered harmful — possess syringe-like molecular machinery that can deliver bacterial proteins into human cells, affecting immune and metabolic signaling. The work also links these bacterial “effector” genes to Crohn’s disease–associated microbiome patterns, though the authors say more studies are needed to determine how the mechanism influences disease.

An Ruwaito ta hanyar AI

A mysterious group of gut bacteria known as CAG-170 appears in higher numbers among healthy individuals, according to a new study. Researchers analyzed microbiomes from over 11,000 people across 39 countries and found this genus strongly associated with good health and balanced gut ecosystems. The findings suggest potential roles in producing vitamin B12 and supporting other microbes, though causality remains unclear.

Researchers at UCLA Health and UC San Francisco have identified a natural defense mechanism in brain cells that helps remove toxic tau protein, potentially explaining why some neurons resist Alzheimer's damage better than others. The study, published in Cell, used CRISPR screening on lab-grown human neurons to uncover this system. Findings suggest new therapeutic avenues for neurodegenerative diseases.

An Ruwaito ta hanyar AI An Binciki Gaskiya

Researchers have developed a genomic mapping technique that reveals how thousands of genes work together to influence disease risk, helping to bridge gaps left by traditional genetic studies. The approach, described in a Nature paper led by Gladstone Institutes and Stanford University scientists, combines large-scale cell experiments with population genetics data to highlight promising targets for future therapies and deepen understanding of conditions such as blood disorders and immune-mediated diseases.

A Northwestern University team reports that redesigning the chemotherapy drug 5‑fluorouracil as a spherical nucleic acid markedly increased its cancer‑cell uptake and efficacy in acute myeloid leukemia models, with no observable side effects, according to a study published October 29 in ACS Nano.

An Ruwaito ta hanyar AI

Researchers at the University of California, Berkeley have identified a methane-producing archaeon that interprets a standard stop codon in two ways, challenging a core principle of biology. The microbe, Methanosarcina acetivorans, sometimes adds an amino acid called pyrrolysine instead of halting protein synthesis. This flexibility may aid in metabolizing compounds linked to human health.

 

 

 

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi